Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthy volunteer skin reactivity study of sub-therapeutic taspoglutide
NL-OMON34382Active, not recruiting
- Sponsor
- Roche
- Start
- Dec 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Single-blind, single-arm trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Dec 2010; status: active, not recruiting.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON34382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34382.